ThermoGenesis Holdings, Inc

(NASDAQ:KOOL)

Latest On ThermoGenesis Holdings, Inc (KOOL):

Date/Time Type Description Signal Details
2024-06-28 05:49 ESTDividendA dividend of $0.02 has been announced on Jun 27, 2024. It will be paid Jul 1, 2024 with an ex-dividend date of Jun 28, 2024.Neutral
2021-08-06 05:26 ESTNewsManycore Tech Pursues $100 Million U.S. IPON/A
2021-07-21 13:14 ESTNewsInterior Design Specialist Manycore Aims To Become China's AutodeskN/A
2020-09-26 13:13 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:19 ESTFinancialsCompany financials have been released.Neutral
2020-08-15 05:00 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:16 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 21:09 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:11 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:09 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:13 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 05:19 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 05:23 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 09:17 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 01:07 ESTFinancialsCompany financials have been released.Neutral
2020-03-07 23:52 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 04:14 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 21:09 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 00:00 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 00:00 ESTFinancialsCompany financials have been released.Neutral
2020-02-07 00:06 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 23:56 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 04:15 ESTEarningsEarnings have been released on September 21, 2016, with -$1.01 earnings per share.Buy
2020-01-28 00:04 ESTFinancialsCompany financials have been released.Neutral
2020-01-24 23:51 ESTFinancialsCompany financials have been released.Neutral
2020-01-16 00:06 ESTFinancialsCompany financials have been released.Neutral
2019-12-28 23:34 ESTStock SplitA stock split has occured on Jun 5, 2019 with a split factor of 10/1.Neutral
2019-12-25 23:36 ESTStock SplitA stock split has occured on Jun 5, 2019 with a split factor of 10/1.Neutral
2019-12-22 03:35 ESTFinancialsCompany financials have been released.Neutral
2019-12-18 23:37 ESTStock SplitA stock split has occured on Jun 5, 2019 with a split factor of 10/1.Neutral
2019-12-16 23:58 ESTFinancialsCompany financials have been released.Neutral
2019-11-28 23:47 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 23:57 ESTFinancialsCompany financials have been released.Neutral
2019-11-26 23:57 ESTFinancialsCompany financials have been released.Neutral
2019-11-21 23:41 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 23:57 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 23:57 ESTStock SplitA stock split has occured on Jun 5, 2019 with a split factor of 10/1.Neutral
2019-11-06 23:54 ESTFinancialsCompany financials have been released.Neutral
2019-11-06 23:54 ESTStock SplitA stock split has occured on Jun 5, 2019 with a split factor of 10/1.Neutral
2019-10-29 06:48 ESTNewsCesca Therapeutics (KOOL) Presents At BIO Investor Forum - SlideshowN/A
2019-10-22 14:06 ESTNewsCesca forms JV to commercialize cell processing platform; shares up 5%N/A
2019-09-23 12:33 ESTNewsHealthcare and Technology names dominate midday moversN/A
2019-09-23 11:01 ESTNewsPlus Therapeutics leads healthcare gainers; Akcea Therapeutics leads the losersN/A
2019-09-10 11:05 ESTNewsMallinckrodt leads healthcare gainers; Cesca Therapeutics among losersN/A
2019-09-10 09:10 ESTNewsWEN, MBOT among premarket losersN/A
2019-09-09 09:18 ESTNewsT, ACAD among premarket gainersN/A
2019-09-09 08:48 ESTNewsCesca Therapeutics up 11% premarket on X-Series products dealN/A

About ThermoGenesis Holdings, Inc (KOOL):

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies for cell-based therapies in the United States, China, rest of Asia, Europe, and internationally. The company operates through two segments, Clinical Development and Device. It offers AutoXpress System, an automated system for the isolation, collection and storage of hematopoietic stem cell concentrates derived from cord blood and peripheral blood; Point-of CareXpress System for the rapid, automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells; CAR-TXpress System that addresses the critical unmet need for chemistry, manufacturing and controls improvement of the emerging CAR-T therapies for cancer patients; BioArchive Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for stem cell samples and clinical products; and manual disposables. The company is also developing autologous stem cell-based therapeutics that address medical needs for applications in the vascular, cardiology, and orthopedic markets. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.

See Advanced Chart

General

  • Name ThermoGenesis Holdings, Inc
  • Symbol KOOL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorOther
  • IndustryOther
  • Full Time Employees 53
  • Last Split Date
  • Fiscal Year EndDecember
  • IPO Date1987-06-04
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLwww.cescatherapeutics.com
View More

Highlights

  • Market Capitalization 12.42 million
  • EBITDA -4261000
  • Analyst Target Price $7.5
  • Book Value Per Share $2.42
View More

Share Statistics

  • % Held by Insiders <1%
View More

Technicals

  • 52 Week High $1.23
  • 52 Week Low $0.44
View More

Dividends

  • Dividend Date
  • ExDividend Date
  • Dividend Yield 0%
View More

ThermoGenesis Holdings, Inc (KOOL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ThermoGenesis Holdings, Inc (KOOL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2019-06-302019-08-13$4.31 million-$0.47-$0.6021.67%
2018-12-312019-03-25$2.69 million-$1.00-$0.70-42.86%
2018-09-302018-11-15$3.11 million-$1.20-$1.00-20%
2018-06-302018-08-14$2 million$0.30-$1.20125%
2017-12-312018-03-22$2.94 million-$2.72
2017-09-302017-11-15$3.07 million$0.06
2017-06-302017-09-19$3.5 million-$1.16
2017-03-312017-05-11$3.25 million-$2.12
2016-06-302016-09-21$5.8 million-$1.01-$1.1512.17%
2015-12-312016-02-17$3.29 million-$40.04
2015-09-302015-11-17$2.82 million-$16.75
2015-06-302015-09-18$3.7 million-$11.75
2015-03-312015-06-24$4.04 million-$23.83
2014-12-312015-02-13$4.64 million-$21.69
2014-06-302014-09-29$3.84 million-$16.37
2014-03-312014-05-16$4.04 million-$13.08
2013-09-302013-11-15$3.64 million-$19.22
2013-06-302013-08-30$4.15 million-$29.01
2013-03-312013-05-15$4.89 million-$13.57
2012-12-312013-02-13$4.8 million-$6.82
2012-06-302012-09-20$4.48 million$12.05
2012-03-312012-05-11$4.91 million-$21.48
2011-12-312012-02-10$4.78 million-$15.61
2011-06-302011-09-13$5.38 million-$14.77
2011-03-312011-05-06$5.17 million-$11.38
2010-12-312011-02-11$5.86 million-$6.92
2010-06-302010-09-15$7.18 million-$0.97
2010-03-312010-05-07$4.76 million-$19.47
2009-12-312010-02-05$5.96 million-$20.94
2009-06-302009-09-10$4.02 million-$31.22
2009-03-312009-05-07$5.15 million-$15.57
2008-12-312009-02-05$6.13 million-$24.20
2008-06-302008-09-10$7.18 million-$38.25
2008-03-312008-05-08$5.65 million-$38.49
2007-12-312008-02-06$5.49 million-$24.66
2007-06-302007-09-12$3.52 million-$33.06
2007-03-312007-05-10$5.21 million-$15.01
2006-12-312007-02-09$3.72 million-$29.45
2006-06-302006-09-07$3.56 million-$15.97
2006-03-312006-05-10$3.25 million-$13.83
2005-12-312006-02-08$3.13 million-$30.49
2005-06-302005-09-09$3.1 million-$35.12
2005-03-312005-05-09$1.73 million-$36.96
2004-12-312005-02-09$2.95 million-$32.66
2004-06-302004-09-10$3.64 million-$33.46
2004-03-312004-05-12$3.37 million-$22.80
2003-12-312004-02-13$2.5 million-$24.30
2003-06-302003-09-24$2.9 million-$25.12
2003-03-312003-05-28$2.89 million-$36.44
2002-12-312003-02-14$2.35 million-$35.93
2002-09-302002-11-12$2.05 million-$30.90
2002-06-302002-06-30$2.83 million-$33.39
2002-03-312002-03-31$2.74 million-$29.32
2001-12-312001-12-31$2.47 million-$24.17
2001-09-302001-09-30$1.52 million-$35.54
2001-06-302001-06-30$1.63 million-$54.39
2001-03-312001-03-31$1.7 million-$38.25
2000-12-312000-12-31$1.6 million-$51.54
2000-09-302000-09-30$864000-$46.30
2000-03-312000-03-31$945000-$50.58
1999-12-311999-12-31-$64.38
1999-09-301999-09-30-$67.37
1999-03-311999-03-31-$136.00
1998-12-311998-12-31-$162.68
1998-09-301998-09-30-$76.28

ThermoGenesis Holdings, Inc (KOOL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Mar 31 2020 Jun 30 2019 Mar 31 2019 Dec 31 2018 Sep 30 2018
Research Development 609000 611000 563000 452000 611000
Income Before Tax -4.74 million -1.48 million -2.05 million -8.57 million -2.76 million
Selling General Administrative 2.09 million 1.6 million 1.6 million 2.34 million 1.94 million
Gross Profit 1.49 million 1.95 million 1.26 million 823000 655000
Ebit -1.21 million -262000 -906000 -1.97 million -1.9 million
Operating Income -1.21 million -262000 -906000 -1.97 million -1.9 million
Income Tax Expense -141000 -178000 -176000 -1.28 million -175000
Total Revenue N/A 4.31 million 2.96 million 2.69 million 3.11 million
Cost of Revenue 1.71 million 2.35 million 1.7 million 1.87 million 2.46 million
Total Other Income Expense Net N/A -1.21 million -1.14 million -6.6 million -865000
Net Income From Continuing Operations -4.6 million -1.48 million -2.05 million -7.3 million -2.76 million
Net Income Applicable to Common Shares -4.6 million -1.3 million -1.87 million -7.16 million -2.59 million
Cash Flow:
Date Mar 31 2020 Jun 30 2019 Mar 31 2019 Dec 31 2018 Sep 30 2018
Investments N/A N/A N/A N/A N/A
Change to Liabilities -147000 525000 316000 579000 -353000
Total Cash Flow from Investing Activities -23000 -104000 -38000 -253000 -135000
Net Borrowings 1.87 million -15000 2.31 million -17000 -9000
Total Cash Flow from Financial Activities 5.13 million 759000 2.32 million -16000 614000
Change to Operating Activities N/A 225000 -1.29 million 525000 414000
Change in Cash 2.57 million 187000 -163000 180000 -851000
Total Cash from Operating Activities -2.54 million -468000 -2.44 million 448000 -1.33 million
Depreciation 721000 190000 212000 164000 173000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory -400000 350000 99000 -275000 694000
Change to Account Receivables N/A -1.1 million -485000 502000 -326000
Other Cash Flow from Financing Activities -13000 -15000 N/A N/A N/A
Change to Net Income 68000 -8000 -9000 5.74 million 208000
Capital Expenditures 23000 104000 38000 253000 135000
Balance Sheet:
Date Mar 31 2020 Dec 31 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Total Liabailities 13.8 million 14.3 million 10.03 million 9.35 million 7.88 million
Total Stockholder Equity 4.22 million 386000 5.72 million 5.32 million 8.44 million
Other Current Liabilities 5.72 million 3.08 million 1.87 million 2.12 million 1.73 million
Total Assets 18.4 million 15.21 million 16.53 million 15.63 million 14.61 million
Common Stock 6000 3000 2000 22000 22000
Other Current Assets 429000 602000 389000 313000 224000
Retained Earnings -241.53 million -236.93 million -230.6 million -229.31 million -227.44 million
Other Liabilities N/A N/A 323000 330000 341000
Other Assets N/A N/A 1.05 million 1.05 million 1.05 million
Cash 6.72 million 4.16 million 2.42 million 2.24 million 2.4 million
Total Current Liabilities 6.48 million 6.69 million 6.48 million 5.61 million 6.37 million
Other Stockholder Equity 40000 2000 -20000 -17000 -13000
Property, Plant & Equipment 1.9 million 2.03 million 3.31 million 3.38 million 2.56 million
Total Current Assets 13.4 million 9.86 million 9.86 million 8.85 million 8.63 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 2 million -1.86 million 3.41 million 2.98 million 6.07 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A 1.41 million 2.4 million 2.56 million 1.17 million
Inventory 4.22 million 3.82 million 3.95 million 4.31 million 4.49 million
Accounts Payable 6.86 million 7.12 million 3.2 million 2.46 million 2.42 million

ThermoGenesis Holdings, Inc (KOOL) Chart:

ThermoGenesis Holdings, Inc (KOOL) News:

Below you will find a list of latest news for ThermoGenesis Holdings, Inc (KOOL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ThermoGenesis Holdings, Inc (KOOL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

ThermoGenesis Holdings, Inc (KOOL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2018-05-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/811212/000000000018013521/0000000000-18-013521-index.htm
2018-05-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/811212/000000000018014691/0000000000-18-014691-index.htm
2018-09-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/811212/000000000018030062/0000000000-18-030062-index.htm
2019-05-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/811212/000000000019008985/0000000000-19-008985-index.htm
2019-02-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/811212/000081121219000001/0000811212-19-000001-index.htm
2018-05-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/811212/000121390018006888/0001213900-18-006888-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918008861/0001437749-18-008861-index.htm
2018-05-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/811212/000143774918009049/0001437749-18-009049-index.htm
2018-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774918009052/0001437749-18-009052-index.htm
2018-05-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/811212/000143774918009467/0001437749-18-009467-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918009767/0001437749-18-009767-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774918009783/0001437749-18-009783-index.htm
2018-05-14S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/811212/000143774918009799/0001437749-18-009799-index.htm
2018-05-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774918009800/0001437749-18-009800-index.htm
2018-05-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/811212/000143774918010060/0001437749-18-010060-index.htm
2018-05-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774918010063/0001437749-18-010063-index.htm
2018-05-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774918010066/0001437749-18-010066-index.htm
2018-05-16S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/811212/000143774918010170/0001437749-18-010170-index.htm
2018-05-17POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774918010238/0001437749-18-010238-index.htm
2018-05-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/811212/000143774918010273/0001437749-18-010273-index.htm
2018-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918010389/0001437749-18-010389-index.htm
2018-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918010518/0001437749-18-010518-index.htm
2018-05-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/811212/000143774918010519/0001437749-18-010519-index.htm
2018-05-31SDhttps://www.sec.gov/Archives/edgar/data/811212/000143774918010997/0001437749-18-010997-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918011187/0001437749-18-011187-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918011226/0001437749-18-011226-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918011617/0001437749-18-011617-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918011737/0001437749-18-011737-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774918012464/0001437749-18-012464-index.htm
2018-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918012626/0001437749-18-012626-index.htm
2018-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918015347/0001437749-18-015347-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774918015505/0001437749-18-015505-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918016299/0001437749-18-016299-index.htm
2018-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774918016408/0001437749-18-016408-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774918016607/0001437749-18-016607-index.htm
2018-09-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/811212/000143774918017196/0001437749-18-017196-index.htm
2018-09-19S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/811212/000143774918017197/0001437749-18-017197-index.htm
2018-09-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774918017378/0001437749-18-017378-index.htm
2018-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918018456/0001437749-18-018456-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918020824/0001437749-18-020824-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774918020827/0001437749-18-020827-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774918022210/0001437749-18-022210-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774918022211/0001437749-18-022211-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774918022279/0001437749-18-022279-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919000084/0001437749-19-000084-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919000299/0001437749-19-000299-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919001583/0001437749-19-001583-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919002431/0001437749-19-002431-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919005613/0001437749-19-005613-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/811212/000143774919005676/0001437749-19-005676-index.htm
2019-04-03PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/811212/000143774919006487/0001437749-19-006487-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919006864/0001437749-19-006864-index.htm
2019-04-22PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/811212/000143774919007639/0001437749-19-007639-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919007871/0001437749-19-007871-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/811212/000143774919008304/0001437749-19-008304-index.htm
2019-05-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/811212/000143774919009644/0001437749-19-009644-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774919009832/0001437749-19-009832-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919009836/0001437749-19-009836-index.htm
2019-05-16S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/811212/000143774919010135/0001437749-19-010135-index.htm
2019-05-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/811212/000143774919010929/0001437749-19-010929-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919011377/0001437749-19-011377-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919012794/0001437749-19-012794-index.htm
2019-07-11SDhttps://www.sec.gov/Archives/edgar/data/811212/000143774919013854/0001437749-19-013854-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919014789/0001437749-19-014789-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919014848/0001437749-19-014848-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774919016575/0001437749-19-016575-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919016613/0001437749-19-016613-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919018012/0001437749-19-018012-index.htm
2019-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919018161/0001437749-19-018161-index.htm
2019-09-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/811212/000143774919018321/0001437749-19-018321-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774919018649/0001437749-19-018649-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774919018650/0001437749-19-018650-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/811212/000143774919018651/0001437749-19-018651-index.htm
2019-09-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919018947/0001437749-19-018947-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919020407/0001437749-19-020407-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919020408/0001437749-19-020408-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919021054/0001437749-19-021054-index.htm
2019-11-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/811212/000143774919023035/0001437749-19-023035-index.htm
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/811212/000143774919023146/0001437749-19-023146-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919023208/0001437749-19-023208-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919023298/0001437749-19-023298-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919023403/0001437749-19-023403-index.htm
2019-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/811212/000143774919023625/0001437749-19-023625-index.htm
2018-05-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/811212/999999999518001270/9999999995-18-001270-index.htm
2018-09-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/811212/999999999518002472/9999999995-18-002472-index.htm
2019-05-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/811212/999999999519001233/9999999995-19-001233-index.htm

ThermoGenesis Holdings, Inc (KOOL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ThermoGenesis Holdings, Inc (KOOL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: < 1%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-08-28THOMIS JOSEPHDirectorBuy35,000.000.186,300.0035,000.00https://www.sec.gov/Archives/edgar/data/811212/000143774918016408/0001437749-18-016408-index.htm